IP Library Patent Application 17526941
Patent Application
App. No. 17/526,941

Antibodies and Methods for the Detection of Cell Death

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/526,941
Abstract

Disclosed herein are antibodies having binding specificity to the amino acid sequences Ala Ser Ser Gly Leu Thr Val Glu Val Asp (SEQ ID NO:1) and Thr Val Glu Val Asp (SEQ ID NO:14), and methods of detecting cell death in a sample, comprising contacting the sample with a first antibody specific for a C-terminal amino acid sequence Ala Ser Ser Gly Leu Thr Val Glu Val Asp (SEQ ID NO:1) or Thr Val Glu Val Asp (SEQ ID NO:14) of a CK18 protein fragment having a C-terminal amino acid sequence of Val Glu Val Asp (SEQ ID NO:2) and a second antibody that specifically binds an epitope that is present in both full-length CK18 and the CK18 protein fragment, and that does not overlap with SEQ ID NO:1 or SEQ ID NO:14, under conditions such that the CK18 protein fragment present in the sample specifically binds to the first antibody and the second antibody, wherein one of the antibodies is bound to a solid support and the other antibody is bound to a detection moiety capable of producing a signal; optionally removing any unbound or excess material; and detecting the signal from the detection moiety, wherein the signal is positively correlated with the presence of the CK18 protein fragment in the sample.

Claims (16)

1 . An antibody wherein the antibody has binding specificity to the amino acid sequence Thr Val Glu Val Asp (SEQ ID NO:14).

2 . The antibody of claim 1 , coupled to a solid support or a detection moiety.

3 . The antibody of claim 2 , wherein the antibody is directly bound to a solid support or a detection moiety.

4 . The antibody of claim 2 , wherein the antibody is indirectly bound to a solid support or a detection moiety.

5 . The antibody of claim 2 , wherein the detection moiety is selected from the group consisting of electrochemiluminescence labels or compounds, chemiluminescent compounds, enzyme labels, fluorophores, chromogenic compounds, radiolabels, catalysts, colorimetric, labeled antibodies, a latex particle, a magnetic particle, a paramagnetic particle, a radioactive element, fluorescent dyes, phosphorescent dyes, dye crystals, gold particles, silver colloidal particles, selenium colloidal particles, metal chelates, coenzymes, electro active groups, oligonucleotides and stable radicals.

6 . The antibody of claim 5 , wherein the metal chelate is a ruthenium, an osmium, or a europium metal chelate.

7 . The antibody of claim 2 , wherein the solid support is selected from the group consisting of a bead, a plate, a glass surface, a plastic surface, a metal surface, a polystyrene surface, a nitrocellulose surface, a microparticle and a nanoparticle surface.

8 . The antibody of claim 7 , wherein the solid support is a bead.

9 . The antibody of claim 1 , wherein the antibody comprises a variable region of the heavy chain amino acid sequence of SEQ ID NO:5, and a variable region of the light chain amino acid sequence of SEQ ID NO:7.

10 . The antibody of claim 9 , coupled to a solid support or a detection moiety.

11 . The antibody of claim 10 , wherein the antibody is directly bound to a solid support or a detection moiety.

12 . The antibody of claim 10 , wherein the antibody is indirectly bound to a solid support or a detection moiety.

13 . The antibody of claim 10 , wherein the detection moiety is selected from the group consisting of electrochemiluminescence labels or compounds, chemiluminescent compounds, enzyme labels, fluorophores, chromogenic compounds, radiolabels, catalysts, colorimetric, labeled antibodies a latex particle, a magnetic particle, a radioactive element, fluorescent dyes, phosphorescent dyes, dye crystallites, gold particles, silver colloidal particles, selenium colloidal particles, metal chelates, coenzymes, electro active groups, oligonucleotides and stable radicals.

14 . The antibody of claim 13 , wherein the metal chelate is a ruthenium, an osmium, or a europium metal chelate.

15 . The antibody of claim 10 , wherein the solid support is selected from the group consisting of a bead, a plate, a glass surface, a plastic surface, a metal surface, a polystyrene surface, a nitrocellulose surface, a microparticle and a nanoparticle surface.

16 . The antibody of claim 15 , wherein the solid support is a bead.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2023
From: DEFINED DIAGNOSTICS, LLC (FORMERLY KNOWN AS WELLSTAT DIAGNOSTICS, LLC)
To: PDL BIOPHARMA, INC.
Reel/Frame 065823/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2023
From: PDL BIOPHARMA, INC.
To: DEFINED DIAGNOSTICS, LLC (F/K/A WELLSTAT DIAGNOSTICS, LLC)
Reel/Frame 065823/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2023
From: MILLER, JEFFREY ALLAN; JEFFRIES, EDDIE PHILLIP
To: WELLSTAT DIAGNOSTICS, LLC.
Reel/Frame 065817/0656 →
CHANGE OF NAME Recorded Dec 8, 2023
From: WELLSTAT DIAGNOSTICS, LLC
To: DEFINED DIAGNOSTICS, LLC
Reel/Frame 066140/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: DEFINED DIAGNOSTICS, LLC (F/K/A WELLSTAT DIAGNOSTICS, LLC)
To: PHARMA CINQ, LLC
Reel/Frame 065769/0601 →